Upstream ORF affects MYCN translation depending on exon 1b alternative splicing

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Besançon, Roger ^a,b   Valsesia Wittmann, Sandrine ^c   Locher, Clara ^a   Delloye Bourgeois, Céline ^a   Furhman, Lydie ^a   Tutrone, Giovani ^a   Bertrand, Christophe ^a   Jallas, Anne Catherine ^c   Garin, Elisabeth ^c   Puisieux, Alain ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; MESSENGER RNA; POLYCLONAL ANTIBODY; PROTEIN MYCN; UNCLASSIFIED DRUG; ISOPROTEIN; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; EXON; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTAGENESIS; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PLASMID; RNA TRANSLATION; WESTERN BLOTTING; ADULT; CELL CULTURE; CELL SURVIVAL; FETUS; GENE DOSAGE; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN SYNTHESIS; RNA SPLICING;

ADULT; ALTERNATIVE SPLICING; BASE SEQUENCE; CELL SURVIVAL; CELLS, CULTURED; EXONS; FETUS; GENE DOSAGE; GENE EXPRESSION; HUMANS; NUCLEAR PROTEINS; ONCOGENE PROTEINS; OPEN READING FRAMES; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; RNA SPLICE SITES; RNA, MESSENGER;

EID: 75649144918     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-445     Document Type: Article

References (34)

1. Schwab M, Varmus HE, Bishop JM, Grzeschik KH, Naylor SL, Sakaguchi AY, et al. Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature 1984, 308:288-291. 10.1038/308288a0, 6700732.
2. Stanton LW, Bishop JM. Alternative processing of RNA transcribed from NMYC. Mol Cell Biol 1987, 7:4266-4272. 368108, 3437890.
3. Ibson JM, Rabbitts PH. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation. Oncogene 1988, 2:399-402.
4. van Bokhoven H, Celli J, van Reeuwijk J, Rinne T, Glaudemans B, van Beusekom E, et al. MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome. Nat Genet 2005, 37:465-467. 10.1038/ng1546, 15821734.
5. Jopling CL, Willis AE. N-myc translation is initiated via an internal ribosome entry segment that displays enhanced activity in neuronal cells. Oncogene 2001, 20:2664-2670. 10.1038/sj.onc.1204404, 11420678.
6. Kochetov AV, Ahmad S, Ivanisenko V, Volkova OA, Kolchanov NA, Sarai A. uORFs, reinitiation and alternative translation start sites in human mRNAs. FEBS Lett 2008, 582:1293-1297. 10.1016/j.febslet.2008.03.014, 18358843.
7. Calvo SE, Pagliarini DJ, Mootha VK. Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans. Proc Natl Acad Sci USA 2009, 106:7507-7512. 10.1073/pnas.0810916106, 2669787,2669787, 19372376.
8. Landry JR, Mager DL, Wilhelm BT. Complex controls: the role of alternative promoters in mammalian genomes. Trends Genet 2003, 19:640-648. 10.1016/j.tig.2003.09.014, 14585616.
9. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 1983, 305:245-248. 10.1038/305245a0, 6888561.
10. Sawai S, Shimono A, Wakamatsu Y, Palmes C, Hanaoka K, Kondoh H. Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development 1993, 117:1445-1455.
11. Knoepfler PS, Cheng PF, Eisenman RN. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev 2002, 16:2699-2712. 10.1101/gad.1021202, 187459, 12381668.
12. Okubo T, Knoepfler PS, Eisenman RN, Hogan BL. Nmyc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation. Development 2005, 132:1363-1374. 10.1242/dev.01678, 15716345.
13. Wakamatsu Y, Watanabe Y, Nakamura H, Kondoh H. Regulation of the neural crest cell fate by N-myc: promotion of ventral migration and neuronal differentiation. Development 1997, 124:1953-1962.
14. Schwab M, Varmus HE, Bishop JM. Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature 1985, 316:160-162. 10.1038/316160a0, 4040214.
15. Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 1997, 16:2985-2995. 10.1093/emboj/16.11.2985, 1169917, 9214616.
16. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985, 313:1111-1116.
17. Pession A, Tonelli R. The MYCN oncogene as a specific and selective drug target for peripheral and central nervous system tumors. Curr Cancer Drug Targets 2005, 5:273-283. 10.2174/1568009054064606, 15975048.
18. Schweigerer L, Ledoux D, Fleischmann G, Barritault D. Enhanced MYCN oncogene expression in human neuroblastoma cells is associated with altered FGF receptor expression and cellular growth response to basic FGF. Biochem Biophys Res Commun 1991, 179:1449-1454. 10.1016/0006-291X(91)91735-U, 1656953.
19. Fulda S, Lutz W, Schwab M, Debatin KM. MycN sensitizes neuroblastoma cells for drug-triggered apoptosis. Med Pediatr Oncol 2000, 35:582-584. 10.1002/1096-911X(20001201)35:6<582::AID-MPO197gt;3.0.CO;2-2, 11107122.
20. Paffhausen T, Schwab M, Westermann F. Targeted MYCN expression affects cytotoxic potential of chemotherapeutic drugs in neuroblastoma cells. Cancer Lett 2007, 250:17-24. 10.1016/j.canlet.2006.09.010, 17141950.
21. Cui H, Li T, Ding HF. Linking of N-Myc to death receptor machinery in neuroblastoma cells. J Biol Chem 2005, 280:9474-9481. 10.1074/jbc.M410450200, 15632181.
22. Ross RA, Spengler BA, Biedler JL. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 1983, 71:741-747.
23. Iacono M, Mignone F, Pesole G. uAUG and uORFs in human and rodent 5'untranslated mRNAs. Gene 2005, 349:97-105. 10.1016/j.gene.2004.11.041, 15777708.
24. Cobbold LC, Spriggs KA, Haines SJ, Dobbyn HC, Hayes C, de Moor CH, et al. Identification of internal ribosome entry segment (IRES)-trans-acting factors for the Myc family of IRESs. Mol Cell Biol 2008, 28:40-49. 10.1128/MCB.01298-07, 2223313, 17967896.
25. Spriggs KA, Cobbold LC, Jopling CL, Cooper RE, Wilson LA, Stoneley M, et al. Canonical initiation factor requirements of the Myc family of internal ribosome entry segments. Mol Cell Biol 2009, 29:1565-1574. 10.1128/MCB.01283-08, 2648239, 19124605.
26. Watatani Y, Ichikawa K, Nakanishi N, Fujimoto M, Takeda H, Kimura N, et al. Stress-induced translation of ATF5 mRNA is regulated by the 5'-untranslated region. J Biol Chem 2008, 283:2543-2553. 10.1074/jbc.M707781200, 18055463.
27. Pendleton LC, Goodwin BL, Solomonson LP, Eichler DC. Regulation of endothelial argininosuccinate synthase expression and NO production by an upstream open reading frame. J Biol Chem 2005, 280:24252-24260. 10.1074/jbc.M500106200, 15851478.
28. Park EH, Lee JM, Pelletier J. The Tie2 5' untranslated region is inhibitory to 5' end-mediated translation initiation. FEBS Lett 2006, 580:1309-1319. 10.1016/j.febslet.2006.01.049, 16457819.
29. Martin MM, Buckenberger JA, Knoell DL, Strauch AR, Elton TS. TGF-beta(1) regulation of human AT(1) receptor mRNA splice variants harboring exon 2. Mol Cell Endocrinol 2006, 249:21-31.
30. Krummheuer J, Johnson AT, Hauber I, Kammler S, Anderson JL, Hauber J, et al. A minimal uORF within the HIV-1 vpu leader allows efficient translation initiation at the downstream env AUG. Virology 2007, 363:261-271. 10.1016/j.virol.2007.01.022, 17331561.
31. Hurlin PJ. N-Myc functions in transcription and development. Birth Defects Res C Embryo Today 2005, 75:340-352. 10.1002/bdrc.20059, 16425253.
32. Jasty R, van Golen C, Lin HJ, Solomon G, Heidelberger K, Polverini P, et al. Bcl-2 and M-Myc coexpression increases IGF-IR and features of malignant growth in neuroblastoma cell lines. Neoplasia 2001, 3:304-313. 10.1038/sj.neo.7900171, 1505862, 11571630.
33. Nanbru C, Prats AC, Droogmans L, Defrance P, Huez G, Kruys V. Translation of the human c-myc P0 tricistronic mRNA involves two independent internal ribosome entry sites. Oncogene 2001, 20:4270-4280. 10.1038/sj.onc.1204548, 11464293.
34. Oyama M, Kozuka-Hata H, Suzuki Y, Semba K, Yamamoto T, Sugano S. Diversity of translation start sites may define increased complexity of the human short ORFeome. Mol Cell Proteomics 2007, 6:1000-1006. 10.1074/mcp.M600297-MCP200, 17317662.